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The present study investigates the antidiabetic potential of 
dried mature roots of Lantana aculeata, a weed belonging to 
verbenaceae family on biochemical profile in alloxan-induced 
diabetic rats. The effects of an ethanolic extract of the dried 
mature roots of Lantana aculeata on serum glucose, total 
cholesterol, triglycerides, plasma insulin and liver glycogen 
were examined in control and experimental groups. Lantana 
aculeata root extract reduced the serum glucose concentration 
at 24, 48 and 72 hours. To verify the activity sub-chronically, 
the extract administered orally in the doses of 25, 50 and 100 
mg/kg to diabetic rats for 30 days, that significantly reduced 
the level of glucose, total cholesterol and triglycerides with an 
increase in insulin and glycogen concentration to near normal 
levels in a dose-dependent manner. The results indicate that 
roots of Lantana aculeata possess antidiabetic potential in 
alloxan-induced diabetic rats. The activity might be due to high 
concentration of oleanolic acid present in the roots. 
 
 




Plants are utilized in native medicines to treat 
several diseases and are one of the main sources 
for active molecules in the discovery of new 
drugs in the modern era. Considered to be of no 
use, plants such as the common weeds that grow 
abundantly in large terrains hold promise in the 
drug discovery which might be very easily 
accessible and economical. Traditional medicines 
have used these weeds as remedies for host of 
diseases according to the literature [1]. Lantana 
aculeata Linn. (family: Verbenaceae) is a 
sprawling weed which grows in plenty in many  
 
 
parts of the world [2]. Various parts of this taxon 
are attributed with medicinal properties [3], 
especially the roots which are used in the 
treatment of malaria, rheumatism and skin rashes 
[4]. While screening the roots for toxicity studies, 
we observed that they were non-toxic and 
possessed excellent hypoglycemic activity [5], 
which is the main characteristic of non-insulin 
dependent diabetes mellitus (NIDDM), a 
multifactorial disease [6]. Despite numerous 
preventive strategies and treatments, more than 
300 million people worldwide are expected to 
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develop diabetes by 2025 [7,8]. Hence researches 
are on full swing to develop effective medicines 
from economical sources, so the mature roots of 
Lantana aculeata were subjected to antidiabetic 
screening in experimentally induced 
hyperglycemic rats. 
 
Materials and Methods 
 
Alloxan monohydrate was purchased from Sigma 
Chemical Company, St Louis, MO, USA. 
Gliclazide was procured from Dr. Reddy’s Lab, 
Hyderabad, India. All the other chemicals used 
were of analytical grade and were purchased from 
commercial sources. The mature roots of L. 
aculeata were collected during the month of 
October - November 2005 from Puducherry, 
India. The plant material was identified and 
authenticated by Dr. P. Jayaraman, Director, 
Plant Anatomy Research Centre, Medicinal Plant 
Research Unit, Chennai, India. A voucher 
specimen has been deposited there for future 
reference (No. PARC/2006/8). About 1 kg of 
mature L. aculeata roots were chopped into small 
pieces, shade dried, coarsely powdered and 
exhaustively extracted with ethanol by cold 
percolation method. After 72 hours, the solvent 
was decanted and distilled-off over boiling 
waterbath. Further concentrations were done 
under reduced pressure using rotary flash 
evaporator and finally dried in a dessicator. The 
yield of the root extract was found to be 0.32% 
(w/w). Preliminary phytochemical screening of L. 
aculeata root extract revealed the presence of 
triterpenoids, phenols, flavonoids, glycosides and 
tannins [9]. A major triterpenoid identified as 
oleanolic acid (3β-hydroxy-olean-12-en-28-oic 
acid) isolated from the root extract, compared 
with an authentic sample, 1H and 13C-NMR 
spectroscopic data [10,11], which has been 
reported to be the major phytoconstituent of the 
genus Lantana [12]. Adult male albino rats of 
Wistar strain weighing 150 - 200 g used for the 
study were obtained from Tamil Nadu University 
of Veterinary and Animal Sciences, Chennai, 
India and maintained according to the guidelines 
of Committee for the Purpose of Control and 
Supervision of Experiments on Animals, 
Chennai, India (Reg. No. 324). The permission of 
the Departmental Ethical Committee was 
obtained for the study and the experiments were 
conducted as per the principles prescribed for 
laboratory animal use. Animals were fed on 
commercial pelleted chow obtained from Poultry 
Research Station, Chennai, India and water was 
provided ad libitum. In the present study, thirty 
six rats were used. Group I: contained six animals 
that served as control. The remaining 30 animals 
were given alloxan intra-peritoneally (120 mg/kg 
body weight) to induce hyperglycemia. After 72 
hours, the hyperglycemic conditions in these 
animals were ensured from their blood glucose 
values which were above 250 mg/dl. Further they 
were segregated into five groups containing six 
animals each and were treated as follows. 
 
Group II - Disease-control (alloxan 120 mg/kg i.p) 
Group III - Diabetic + Glidazide (25 mg/kg of Body wt) 
Group IV - Diabetic + L. aculeata root (25 mg/kg of Body wt) 
Group V - Diabetic + L. aculeata root (50 mg/kg of Body wt) 
Group VI - Diabetic + L. aculeata root (100 mg/kg of Body wt) 
 
The doses of Lantana aculeata root extract were 
chosen based on earlier preliminary toxicity 
studies [5]. Serum glucose concentration was 
measured at 24, 48 and 72 hours from the blood 
samples drawn by reto-orbital puncture [13]. The 
doses was continued for 30 days and on day 31, 
the animals were sacrificed by cervical 
decapitation under mild anesthesia and the blood 
were collected in tubes with clot activators and 
heparin to get serum and plasma while the liver 
was removed immediately, washed with ice-cold 
saline and stored in deep freezer at -20ºC for 
glycogen estimation. Plasma insulin was 
estimated by ELISA method using Biotech-ELX-
50, (U.S.) [14], liver glycogen using UV visible 
spectrophotometer [15], Serum glucose [13], total 
cholesterol and triglycerides [16,17] were 
estimated using Randox-daytona fully automated 
random axis analyzer (U.K.). Statistical 
evaluation of analytical data was done by 
Student's t-test using SPSS package. The values 
are expressed as the mean ± standard Deviation 
(S.D) and values with P<0.01, P<0.001, P<0.05 
were considered significant. 




Table 1 shows the effect of Lantana aculeata root 
extract on serum glucose level in hyperglycemic 
animals. The level of glucose in animals treated 
with gliclazide and Lantana aculeata root extract 
(25 mg/kg) for 24, 48 and 72 hours showed a 
decrease in the level of glucose. In 50 and 100 
mg/kg dose, the level of glucose further 
decreased with 24, 48 and 72 hours, the decrease 
was drastic in 72 hours. On observing the 
response with 100 mg/kg dose for 72 hours, the 
level of glucose was found near to the control 
value, thereby indicating the ntidiabetic potential 
of Lantana aculeata root. Table 2 illustrates the 
effect of Lantana aculeata root extract for a sub-
chronic period of 30 days. The diabetic control 
rats (Group II) showed a significant increase in 
glucose, total cholesterol and Triglycerides 
levels, while plasma insulin and liver glycogen 
were reduced drastically when compared to the 
control animals. On treatment with standard drug 
gliclazide, all the parameters found to attain near 
normal values. The animals treated with Lantana 
aculeata root extract in different doses (25, 50 
and 100 mg/kg) showed dose-dependent decrease 
in levels of glucose, total cholesterol and 
triglycerides while increase in plasma insulin and 
liver glycogen were obtained when compared to 
the disease-control group. 
Table 1 Effect of Lantana aculeata root extract (LAR) 
on serum glucose (mg/dl) levels in hyperglycemic rats 
for 24, 48 and 72 hours 
 
Treatment 








































































 Values represent mean ± S.D. of six animals 
 *P< 0.05, **P<0.01, ***P<0.001 when compared 
to control animals; NS -Non-significant 
Table 2 Anti diabetic effect of Lantana aculeata root extract (LAR) treated in alloxan-induced rats for 30 days  
 
Treatment (mg/kg) Serum glucose (mg/dl) 








Group I - Control 114.00 ± 6.06 13.50 ± 2.81 58.17 ± 3.12 65.17 ± 3.54 68.17 ± 4.02 
Group II  
Diabetic control 
Alloxan 120mg/kg 














Group III  
Standard drug  
Gliclazide 25 mg/kg 














Group IV  
















Group V  
LAR 50 mg/kg 
102.67 ±  5.92 
b*** 12.00 ± 1.89 
b*** 55.50 ± 5.58 b*** 62.50 ± 4.04 b*** 62.67 ± 5.92 b*** 
Group VI  
LAR 100 mg/kg 
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92.00 ± 5.09 b*** 15.57 ± 3.38 b*** 58.67 ± 4.72 b*** 53.00 ± 5.44 b*** 58.17 ± 5.07 b*** 
 
 Values represent mean ± S.D. of six animals 
 *P< 0.05, **P<0.01, ***P<0.001 when compared to control animals; NS -Non-significant 




The results of antidiabetic study clearly showed 
that Lantana aculeata root extract produced a 
significant hypoglycemic action. At 25 mg/kg 
dose, the activity of Lantana aculeata root extract 
in lowering the serum glucose and promoting 
glycogen storage was found to be higher than the 
standard drug. The possible mechanism for this 
action might be due to the inhibition of the 
enzyme glycogen phosphorylase, an enzyme that 
catalyzes the process of glycogenolysis thereby 
inhibiting glucagon which on feedback inhibition 
favours the production of insulin as reported by 
Liu [18], who also proposed the role of maslinic 
acid (a pentacyclic tritepene obtained by the 
semi-synthesis starting from readily available 
oleanolic acid) in reducing the blood glucose 
level. Our studies showed a high concentration of 
oleanolic acid in L. aculeata roots [5]. The role of 
oleanolic acid in reducing blood glucose level 
was also substantiated by Dawei [19] who 
isolated the compound from Ligustrumlucidum. 
Oleanolic acid has also been indicated to be the 
causative factor for the increase of insulin which 
plays an important role in the glycogenesis 
(Storage of glycogen in the liver) and lipogenesis 
(metabolism of lipids) [20]. This might be the 
cause for drastic depletion of glucose and lipid 
parameters such as total cholesterol and 
triglyceride in hyperglycemic condition [19]. Our 
observations on the antihyperglycemic activity of 
L. aculeata root in diabetic rats as well as the 
isolation of high yield of oleanolic acid from the 
root extract go along with these findings. Further 
studies are necessary to determine the exact 
nature of the active principles and mechanism of 




From this study we can conclude that Lantana 
aculeata root extract has beneficial effects on 
blood glucose and lipid abnormalities. It has the 
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